22.4 EBDVD Revision Strategy & Cross-Topic Review

22.4 EBDVD Revision Strategy & Cross-Topic Review

This closing section turns the official examination rules into a revision plan. It then reviews image-reading technique and the cross-topic safety traps that link chapters. Exam facts (timetable, session topics, pass rule) come from the official UEMS-EBDV page and are set out in full in Section 1.1. The revision advice here is study guidance from this guide, not official Board advice.

Plan Revision by Session, Not by Total Score

The EBDVD is non-compensatory: you need 22 of 40 (55%) in each of the five sessions. The practical consequence is to revise so that no session is weak, rather than piling up marks in favourite topics.

A 12-Week Revision Outline

1. Weeks 1–4: one pass through every chapter. Mark each session as strong, adequate, or weak using the practice questions at the end of each section.
2. Weeks 5–8: a second pass focused on the two weakest sessions. Make one-page summaries of tables that recur across topics: autoantigens, staging systems, drug monitoring, and STI regimens.
3. Weeks 9–11: timed blocks of 40 questions in 60 minutes, one block per session. Treat any block below about 60% as a warning, since the real pass mark of 55% leaves little margin.
4. Week 12: light review of numbers you tend to forget (margins, doses, criteria), the official logistics, and the image routine below. Attend the mandatory test meeting.

Pacing on the Day

• Each session gives you 60 minutes for 40 questions, an average of 90 seconds per question.
• A useful rhythm is a first pass answering clear questions quickly and marking hard image questions, then a second pass for the marked items. Leave nothing blank: there is no negative marking.
• The official timetable gives 15-minute breaks after Sessions 1, 2, and 4 and a one-hour break (12:30–13:30) after Session 3. Use breaks to rest, not to re-check earlier answers you can no longer change.
• Each session is scored separately, so a hard morning session does not decide the afternoon. Treat every session as a fresh 40-question test.

Clinical Slide and Image Interpretation Protocol

The official examination includes a clinical slide collection, and image-based questions can draw on clinical photographs, dermoscopy, histopathology, immunofluorescence, and microbiology. The Board does not publish what proportion of questions use images. A fixed, five-step routine helps you read any image the same way under time pressure.

The 5-Step Image Interpretation Algorithm

1. Step 1: Orientation & Anatomical Site Identification:
   • Determine the exact anatomical location: Is it sun-exposed (malar face, V of neck, dorsal forearms) suggesting photo-induced disorders (polymorphic light eruption, SCLE, porphyria cutanea tarda, solar elastosis) or photoprotected (axillae, buttocks, inguinal folds)?
   • Is the lesion flexural / intertriginous (inverse psoriasis, erythrasma, candidiasis, Hailey-Hailey disease, hidradenitis suppurativa) or extensor (plaque psoriasis, dermatitis herpetiformis, xanthomas)?
   • Are mucous membranes involved (oral, genital, conjunctival), directing thinking toward lichen planus, pemphigus vulgaris, mucous membrane pemphigoid, Stevens-Johnson syndrome, or Behçet disease?
2. Step 2: Primary Lesion Morphology Analysis:
   • Identify the fundamental primary lesion before considering secondary changes:
     • Macule / Patch: Flat circumscribed alteration in color (<1 cm vs >=1 cm).
     • Papule / Plaque: Solid elevated lesion (<1 cm vs >=1 cm).
     • Nodule: Deep, circumscribed, palpable solid dermal/subcutaneous lesion (>1 cm).
     • Vesicle / Bulla: Fluid-filled circumscribed blister (<1 cm vs >=1 cm).
     • Wheal: Transient erythematous, edematous dermal swelling with rapid resolution.
     • Pustule: Circumscribed epidermal collection of purulent exudate.
3. Step 3: Configuration & Distribution Patterns:
   • Linear: Suggests external trauma/contact (phytophotodermatitis, toxic contact dermatitis), Koebner phenomenon (psoriasis, lichen planus, vitiligo), or mosaicism along lines of Blaschko (incontinentia pigmenti, linear epidermal nevus, linear morphea).
   • Annular / Polycyclic: Centrifugal expansion with active borders: tinea corporis, subacute cutaneous lupus erythematosus (SCLE), erythema annulare centrifugum, granuloma annulare, urticaria.
   • Targetoid (Iris) Lesions: Concentric three-zone architecture (central dusky/necrotic zone, surrounding pale edematous ring, outer erythematous halo): pathognomonic for erythema multiforme.
   • Reticular / Livedoid: Net-like vascular branching: livedo reticularis (vasospastic), livedo racemosa (organic arteriolar occlusive disease e.g. Sneddon syndrome, antiphospholipid syndrome), livedoid vasculopathy.
   • Dermatomal / Herpetiform: Grouped umbilicated vesicles on an erythematous base following a dermatome (herpes zoster) or grouped excoriated vesicles on extensor sites (dermatitis herpetiformis).
4. Step 4: Special Modalities Integration (Dermoscopy, Histopathology, DIF):
   • Dermoscopy: Examine architectural symmetry, pigment networks (atypical/broadened in melanoma vs delicate in naevi), vascular patterns (arborizing telangiectasias in basal cell carcinoma; dotted/glomerular vessels in psoriasis or clear cell acanthoma; hairpin vessels with white halos in keratoacanthoma/SCC; crown vessels in sebaceous hyperplasia; blue-white veil and chrysalis structures in melanoma).
   • Histopathology:
     • Epidermal reaction pattern: Hyperkeratosis with parakeratosis and absent granular layer (psoriasiform); spongiotic intraepidermal edema (eczematous); interface dermatitis with vacuolar degeneration (lupus, dermatomyositis) or dense band-like lichenoid infiltrate (lichen planus); acantholytic intraepidermal suprabasal splitting (pemphigus vulgaris).
     • Dermal infiltrate composition: Neutrophils in dermal papillae tips (dermatitis herpetiformis); dense eosinophils (bullous pemphigoid, Wells syndrome); palisading granulomas around necrobiotic collagen (granuloma annulare, necrobiosis lipoidica); non-caseating sarcoidal naked granulomas (sarcoidosis).
   • Direct Immunofluorescence (DIF):
     • Intraepidermal intercellular ("chicken-wire" or net-like) IgG and C3: Pemphigus vulgaris (anti-desmoglein 3/1) and pemphigus foliaceus (anti-desmoglein 1).
     • Continuous linear deposition of IgG and/or C3 along the dermo-epidermal junction (BMZ): Bullous pemphigoid (anti-BP180 / BP230).
     • Granular IgA deposition exclusively in the dermal papillae tips: Dermatitis herpetiformis (anti-epidermal transglutaminase).
     • Granular continuous or interrupted IgG, IgM, IgA, and C3 along the BMZ on sun-exposed and sun-protected skin: Lupus Band Test in systemic lupus erythematosus.
5. Step 5: Clinical Synthesis:
   • Combine the clinical, dermoscopic, histological, and immunological findings into one diagnosis. Then answer the actual question asked (next investigation, first-line treatment, or complication), using the European guideline position where one exists.

---

---

Cross-Topic Safety Traps

These traps cross chapter boundaries. Each one is taught in detail in its own section and gathered here for revision.

Trap 1: Drug-Induced SCLE Misidentified as Plaque Psoriasis

• The Trap: A patient develops widespread scaly, erythematous annular or polycyclic plaques on the upper back and chest shortly after initiating a new systemic drug (e.g., terbinafine, hydrochlorothiazide, calcium channel blockers, or anti-TNF biologics). The extensive scaling leads candidates to mistakenly diagnose psoriasis or tinea incognito.
• The Key Point: Histopathology of SCLE shows interface vacuolar dermatitis, basal layer liquefaction, necrotic keratinocytes (apoptotic Civatte bodies), and dermal mucin, with epidermal atrophy—the complete opposite of the regular acanthosis, elongated rete ridges, and absent granular layer of psoriasis. Testing reveals circulating anti-Ro/SSA antibodies in >80% to 90% of cases.

Trap 2: Pemphigoid Nodularis Mistaken for Prurigo Nodularis

• The Trap: An elderly patient has multiple intensely itchy, excoriated, hyperkeratotic nodules on the limbs, labelled chronic prurigo nodularis, which do not respond to potent topical steroids.
• The Key Point: Bullous pemphigoid can present without blisters, including as a prurigo-like eruption (pemphigoid nodularis). In an elderly patient with refractory prurigo, take a perilesional biopsy for direct immunofluorescence and test serum for anti-BP180 and anti-BP230 antibodies. Linear IgG and C3 along the basement membrane zone confirms pemphigoid and changes treatment.

Trap 3: Initiating Dapsone Without Quantitative G6PD Testing

• The Trap: A patient with confirmed dermatitis herpetiformis is prescribed oral dapsone without prior laboratory enzyme testing, resulting in acute hemolytic crisis, cyanosis, and hemoglobinuria 72 hours later.
• The Key Point: Quantitative glucose-6-phosphate dehydrogenase (G6PD) activity must be verified prior to initiating dapsone. G6PD-deficient red blood cells cannot regenerate NADPH, rendering them vulnerable to catastrophic oxidative hemolysis and severe methemoglobinemia induced by dapsone's hydroxylamine metabolite. Baseline reticulocytes, CBC, and methemoglobin levels must be documented.

Trap 4: Initiating Biologics Without Latent TB and Viral Hepatitis Screening

• The Trap: A candidate selects immediate initiation of an anti-TNF (adalimumab, certolizumab) or anti-IL-17 (secukinumab) agent for severe psoriasis without pre-treatment infectious screening.
• The Key Point: European guidelines mandate mandatory screening for latent tuberculosis infection (LTBI) via an Interferon-Gamma Release Assay (IGRA / QuantiFERON) or tuberculin skin test, combined with a chest radiograph, prior to administering any biologic or JAK inhibitor. In addition, complete hepatitis B serology (HBsAg, anti-HBc total, anti-HBs), hepatitis C antibody, and HIV testing are obligatory. TNF-alpha is essential for maintaining tuberculous granuloma integrity; anti-TNF therapy without prior isoniazid prophylaxis triggers fatal disseminated or extrapulmonary tuberculosis reactivation.

Trap 5: Misdiagnosing Early Necrotizing Fasciitis as Simple Cellulitis

• The Trap: A patient presents with an erythematous, warm, swollen calf diagnosed as uncomplicated cellulitis and prescribed oral flucloxacillin. Over the next 12 hours, the patient deteriorates into septic shock.
• The Key Point: The cardinal early diagnostic sign of necrotizing fasciitis is pain out of proportion to physical findings. Red flags indicating deep fascial necrosis include: skin anesthesia/numbness (due to cutaneous nerve ischemia), hemorrhagic bullae, purpuric/violaceous discoloration, woody induration extending beyond the erythema margin, subcutaneous gas/crepitus, and systemic hypotension. Immediate emergency surgical exploration and fasciotomy are required; waiting for imaging or antibiotic response is fatal.

Trap 6: Sharp Debridement of Pyoderma Gangrenosum

• The Trap: A surgeon or dermatologist performs aggressive sharp surgical debridement or wedge excision on an expanding, painful pretibial ulcer with purulent discharge.
• The Key Point: Pyoderma gangrenosum exhibits profound pathergy—the induction of massive, sterile neutrophilic tissue destruction in response to minor trauma. Sharp surgical debridement provokes catastrophic, explosive ulcer enlargement. Treatment requires immediate medical immunosuppression (high-dose systemic corticosteroids or cyclosporine), while debridement is strictly contraindicated.

---

---

High-Yield Summary Revision Matrix

---

---

Final Checklist (Official Logistics)

Before the Examination

• Application submitted before the deadline (1 April for 2026) and fee received in full before the payment deadline (31 May for 2026).
• Official Acceptance E-mail received after the payment check.
• Test meeting attended 1–2 weeks before the examination; computer and phone prepared using the Orzone preparation instructions.
• Remote candidates: approved secure room, room photo sent, signed Consent to Invigilate returned, invigilator confirmed, and no iPad-type device.
• On-site candidates: your own computer meeting the requirements, and accommodation in Frankfurt arranged yourself.

On the Day

• Passport or ID card ready. Candidates paying the EU/EEA/Swiss rate must show an ID document from one of those countries.
• Registration from 08:00 CEST; introduction at 08:50; Session 1 starts at 09:00.
• Desk cleared of phones, wallets, notes, books, calculators, and other electronic devices.
• No photographs, recordings, or notes of questions; keystrokes are monitored.

After the Examination

• Results within 3 weeks; request your individual score in writing if you want it.
• Appeals or a results breakdown: within 1 month of the results.
• If unsuccessful: up to two retakes within three years, retaking only the failed sessions at the full fee.